bromodeoxyuridine has been researched along with amsacrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epe, B; Hoehn, H; Poot, M | 1 |
| Darzynkiewicz, Z; Juan, G; Traganos, F | 1 |
| Barbier, M; Bignon, J; Boutonnat, J; Colle, PE; Faussat, AM; Marie, JP; Ronot, X; Thierry, J; Wdzieczak-Bakala, J | 1 |
3 other study(ies) available for bromodeoxyuridine and amsacrine
| Article | Year |
|---|---|
Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
Topics: Amsacrine; Bromodeoxyuridine; Camptothecin; Cell Line; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Fanconi Anemia; Flow Cytometry; G2 Phase; Humans; Lymphocytes; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Cell-cycle analysis of drug-treated cells.
Topics: Acids; Amsacrine; Antineoplastic Agents; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cyclins; DNA; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Hot Temperature; Humans; Immunohistochemistry; Nucleic Acid Denaturation; Topoisomerase I Inhibitors | 2001 |
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP.
Topics: Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Proliferation; Cytarabine; Daunorubicin; DNA; Etoposide; Flow Cytometry; Fluorescent Dyes; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrocarbons, Chlorinated; Leukemia; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Oligopeptides; Organic Chemicals; Radiation-Protective Agents | 2005 |